BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abad CLR, Razonable RR. Mycobacterium tuberculosis after solid organ transplantation: A review of more than 2000 cases. Clin Transplant. 2018;32:e13259. [PMID: 29656530 DOI: 10.1111/ctr.13259] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Cahuayme-Zuniga LJ, Brust KB. Mycobacterial Infections in Patients With Chronic Kidney Disease and Kidney Transplantation. Adv Chronic Kidney Dis 2019;26:35-40. [PMID: 30876615 DOI: 10.1053/j.ackd.2018.09.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Zou J, Wang T, Qiu T, Chen Z, Zhou J, Ma X, Jin Z, Xu Y, Zhang L. Clinical characteristics of tuberculous infection following renal transplantation. Transpl Immunol 2022;70:101523. [PMID: 34973371 DOI: 10.1016/j.trim.2021.101523] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chung H, Kim SH, Jo KW, Shim TS, Park GC, Kim KH, Lee SO, Lee SG. Clinical Characteristics and Risk Factors of Early-Onset Tuberculosis After Liver Transplantation. Transplant Proc 2021;53:1694-9. [PMID: 34016463 DOI: 10.1016/j.transproceed.2021.04.016] [Reference Citation Analysis]
4 Deziel PJ, Razonable R. Anti-infective chemoprophylaxis after solid-organ transplantation. Expert Rev Clin Immunol 2018;14:469-79. [PMID: 29764228 DOI: 10.1080/1744666X.2018.1476852] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Fellag M, Loukil A, Drancourt M. The puzzle of the evolutionary natural history of tuberculosis. New Microbes New Infect 2021;41:100712. [PMID: 33996102 DOI: 10.1016/j.nmni.2020.100712] [Reference Citation Analysis]
6 Silva JT, Fernández-Ruiz M, Hernández-Jimenez P, San Juan R, Calvo J, García-Sesma Á, Manrique A, Justo I, Caso O, Cambra F, Marcacuzco A, López-Medrano F, Jimenez C, Lumbreras C, Loinaz C, Aguado JM. Experience With Moxifloxacin for the Treatment of Latent Tuberculosis Infection in Liver Transplantation: A Single-Center Prospective Study. Liver Transpl 2021;27:913-7. [PMID: 33615677 DOI: 10.1002/lt.25961] [Reference Citation Analysis]
7 Kwon DE, Han SH, Han KD, La Y, Lee KH. Incidence rate of active tuberculosis in solid organ transplant recipients: Data from a nationwide population cohort in a high-endemic country. Transpl Infect Dis 2021;23:e13729. [PMID: 34505751 DOI: 10.1111/tid.13729] [Reference Citation Analysis]
8 Gomila-Grange A, Pérez-Recio S, Camprubí-Ferrer D, Lladó L, Fava A, García-Romero E, Grijota-Camino MD, Sabé N, Santin M. Rifabutin for treating tuberculosis in solid organ transplant recipients: A retrospective observational study and literature review. Transpl Infect Dis 2021;23:e13471. [PMID: 32959494 DOI: 10.1111/tid.13471] [Reference Citation Analysis]
9 Abad CLR, Deziel PJ, Razonable RR. Treatment of latent TB Infection and the risk of tuberculosis after solid organ transplantation: Comprehensive review. Transpl Infect Dis 2019;21:e13178. [PMID: 31541575 DOI: 10.1111/tid.13178] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
10 Lamm K, Jacobs C, Russo MW. A Case Series of Extrapulmonary Mycobacterium in Liver Transplant Recipients. ACG Case Rep J 2021;8:e00571. [PMID: 34549057 DOI: 10.14309/crj.0000000000000571] [Reference Citation Analysis]
11 Nasir N, Sarfaraz S, Khanum I, Ansari T, Nasim A, Dodani SK, Luxmi S. Tuberculosis in Solid Organ Transplantation: Insights from TB Endemic Areas. Curr Infect Dis Rep 2021;23. [DOI: 10.1007/s11908-021-00756-z] [Reference Citation Analysis]
12 Subramanian AK, Theodoropoulos NM; Infectious Diseases Community of Practice of the American Society of Transplantation. Mycobacterium tuberculosis infections in solid organ transplantation: Guidelines from the infectious diseases community of practice of the American Society of Transplantation. Clin Transplant 2019;33:e13513. [PMID: 30817030 DOI: 10.1111/ctr.13513] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
13 Wang R, Longworth SA, Doyon JB, Lee I, Bloom RD, Romano CM, Veasey SL, Blumberg EA. Active Tuberculosis After Solid Organ Transplantation in Individuals With Negative Pretransplant QuantiFERON-TB Gold Testing: A Case Series. Transplantation Proceedings 2022. [DOI: 10.1016/j.transproceed.2021.11.030] [Reference Citation Analysis]
14 Gibb J, Wong D. Risk stratification and management of QuantiFERON-positive solid-organ living donors. Curr Opin Organ Transplant 2020;25:351-6. [PMID: 32618720 DOI: 10.1097/MOT.0000000000000787] [Reference Citation Analysis]
15 Jones JM, Vikram HR, Lauzardo M, Hill A, Jones J, Haley C, Seaworth B, Oldham S, Brown M, Gutierrez F, Basavaraju SV. Tuberculosis transmission across three states: The story of a solid organ donor born in an endemic country, 2018. Transpl Infect Dis 2020;22:e13357. [PMID: 32510808 DOI: 10.1111/tid.13357] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Friedman DZP, Doucette K. Mycobacteria: Selection of Transplant Candidates and Post-lung Transplant Outcomes. Semin Respir Crit Care Med 2021;42:460-70. [PMID: 34030207 DOI: 10.1055/s-0041-1727250] [Reference Citation Analysis]
17 Malinis M, Koff A. Mycobacterium tuberculosis in solid organ transplant donors and recipients. Curr Opin Organ Transplant 2021;26:432-9. [PMID: 34074939 DOI: 10.1097/MOT.0000000000000885] [Reference Citation Analysis]
18 Roberts SC, Ison MG. Donor-Derived Disease Transmission in Lung Transplantation. Curr Pulmonol Rep 2020;9:1-9. [DOI: 10.1007/s13665-020-00245-z] [Reference Citation Analysis]
19 Wang JY, Brown RA, Pugliese S, Kwong BY, Novoa RA. Disseminated tuberculosis presenting as medium-vessel vasculitis in an immunocompromised host. J Cutan Pathol 2020;47:725-8. [PMID: 32133689 DOI: 10.1111/cup.13678] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Silva JT, San-Juan R, Fernández-Ruiz M, Aguado JM. Fluoroquinolones for the treatment of latent Mycobacterium tuberculosis infection in liver transplantation. World J Gastroenterol 2019; 25(26): 3291-3298 [PMID: 31341356 DOI: 10.3748/wjg.v25.i26.3291] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Dulek DE, Mueller NJ; AST Infectious Diseases Community of Practice. Pneumonia in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019;33:e13545. [PMID: 30900275 DOI: 10.1111/ctr.13545] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
22 Ramírez-Sánchez IC, García K, Nieto-Ríos JF. Multifocal skeletal tuberculosis with mycobacteremia after kidney transplantation: A case report. Transpl Infect Dis 2021;:e13591. [PMID: 33655691 DOI: 10.1111/tid.13591] [Reference Citation Analysis]
23 Genestet C, Paret R, Pichat C, Berland JL, Jacomo V, Carret G, Fredenucci I, Hodille E, Rasigade JP, Boisset S, Carricajo A, Lina G, Ronnaux-Baron AS, Mornex JF, Grando J, Sénéchal A, Ader F, Dumitrescu O; Lyon TB study group. Routine survey of Mycobacterium tuberculosis isolates reveals nosocomial transmission. Eur Respir J 2020;55:1901888. [PMID: 31806715 DOI: 10.1183/13993003.01888-2019] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Abad CLR, Razonable RR. An update on Mycobacterium tuberculosis infection after hematopoietic stem cell transplantation in adults. Clin Transplant 2018;32:e13430. [PMID: 30347465 DOI: 10.1111/ctr.13430] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
25 Clemente WT, Faria LC, Cota GF, Amado LRN, Oliveira JGF, de Miranda SS, Cançado OL Jr, Romanelli RMC, Lima AS, Frade LB, Lucas F Jr, Sanches MD. Donor-Derived Tuberculosis: A Case Report and the Role of Communication Gaps in Transplantation Safety. Case Rep Transplant 2021;2021:8816426. [PMID: 33959403 DOI: 10.1155/2021/8816426] [Reference Citation Analysis]
26 Abad CLR, Razonable RR. Donor derived Mycobacterium tuberculosis infection after solid-organ transplantation: A comprehensive review. Transpl Infect Dis 2018;20:e12971. [PMID: 30055041 DOI: 10.1111/tid.12971] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
27 Mella A, Mariano F, Dolla C, Gallo E, Manzione AM, Di Vico MC, Cavallo R, De Rosa FG, Costa C, Biancone L. Bacterial and Viral Infection and Sepsis in Kidney Transplanted Patients. Biomedicines 2022;10:701. [DOI: 10.3390/biomedicines10030701] [Reference Citation Analysis]
28 Di Dato F, Nunziata F, Rosa M, Iorio R, Spagnuolo MI. Tubercular hemoptysis in a young liver transplanted patient: Case report. Medicine (Baltimore) 2019;98:e16761. [PMID: 31415374 DOI: 10.1097/MD.0000000000016761] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Abad CL, Razonable RR. Prevention and treatment of tuberculosis in solid organ transplant recipients. Expert Rev Anti Infect Ther 2020;18:63-73. [PMID: 31826668 DOI: 10.1080/14787210.2020.1704255] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Thitisuriyarax S, Vanichanan J, Udomkarnjananun S, Townamchai N, Jutivorakool K. Risk factors and clinical outcomes of tuberculosis among kidney transplant recipients in high endemic country. Transpl Infect Dis 2021;23:e13566. [PMID: 33428318 DOI: 10.1111/tid.13566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]